Natixis Investment Managers International Pfizer Inc Transaction History

Natixis Investment Managers International

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $403,647 - $478,599	8,675 Added 18.03%	56,793 $2.98 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $2.2 Million - $2.73 Million	48,118 New	48,118 $2.49 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $3.42 Million - $3.9 Million	-88,857 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $510,500 - $619,206	14,810 Added 20.0%	88,857 $3.92 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $657,753 - $701,231	19,944 Added 36.86%	74,047 $2.69 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $1.73 Million - $2 Million	54,103 New	54,103 $1.92 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $1.35 Million - $1.43 Million	-40,572 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $374,418 - $412,463	-12,078 Reduced 22.94%	40,572 $1.45 Million
Q2 2017 Aug 14, 2017	BUY	N/A	52,650	52,650 $1.77 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Natixis Investment Managers International, based on Form 13F filings with the SEC.

Stay updated on Natixis Investment Managers International with notifications on news.